Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
Sign Up to like & getrecommendations! Published in 2019 at "Drugs"
DOI: 10.1007/s40265-019-01120-1
Abstract: Pegaspargase (Oncaspar®), a pegylated form of native Escherichia coli-derived l-asparaginase (hereafter referred as E. colil-asparaginase), is indicated in the USA and EU for the treatment of acute lymphoblastic leukaemia (ALL) as a component of multi-agent… read more here.
Keywords: colil asparaginase; treatment; pegaspargase; paediatric adult ... See more keywords